BPGAM
ASPX

BTG Pactual Global Asset Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BTG Pactual Global Asset Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-55,300
Closed -$5.54M – 265
2015
Q1 		$5.54M Buy
+55,300
New +$3.68M 0.43% 62

BTG Pactual Global Asset Management's ASPX Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 55,300 shares — an estimated $5.54M sold.

BTG Pactual Global Asset Management first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $5.54M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BTG Pactual Global Asset Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 55,300 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $5.54M.
  • BTG Pactual Global Asset Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $5.54M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.